Segall Bryant & Hamill’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Segall Bryant & Hamill’s Portfolio ARNA Stock Details ARNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-411,550	Closed	-$38.2M	–	774
2021 Q4	$38.2M	Buy	411,550 +17,784	+5%	+$1.17M	0.35%	86
2021 Q3	$23.4M	Buy	393,766 +247,704	+170%	+$14.6M	0.22%	113
2021 Q2	$9.96M	Buy	+146,062	New	+$9.52M	0.1%	214

Segall Bryant & Hamill's ARNA Position: Q1 2022 in Review

Segall Bryant & Hamill sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2022, closing a stake of 411,550 shares — an estimated $38.2M sold.

Segall Bryant & Hamill first reported a position in ARNA in Q2 2021 and held it in 3 quarters. The position peaked at $38.2M in Q4 2021. 1 fund tracked by Wall St. Rank holds ARNA as of Q1 2022.

Segall Bryant & Hamill reported no remaining Arena Pharmaceuticals Inc position as of Q1 2022 after selling out during the quarter.
Segall Bryant & Hamill sold 411,550 Arena Pharmaceuticals Inc shares in Q1 2022, an estimated $38.2M.
Segall Bryant & Hamill first reported a position in Arena Pharmaceuticals Inc in Q2 2021 and held it in 3 quarters.
Segall Bryant & Hamill's Arena Pharmaceuticals Inc position peaked at $38.2M in Q4 2021.
1 fund tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2022.

Based on Segall Bryant & Hamill's 13F filing for Q1 2022, filed 13 May 2022.